TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Edwards Lifesciences Nordic AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
519,608
|
492,949
|
449,607 |
| Financial expenses |
1,983
|
1,041
|
597 |
| Earnings before taxes |
20,554
|
24,249
|
15,284 |
| EBITDA |
22,416
|
25,369
|
16,140 |
| Total assets |
163,767
|
178,305
|
155,021 |
| Current assets |
163,038
|
177,866
|
154,341 |
| Current liabilities |
73,369
|
102,117
|
96,155 |
| Equity capital |
87,036
|
72,748
|
51,706 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
36
|
31
|
34 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
53.1%
|
40.8%
|
33.4% |
| Turnover per employee |
14,434
|
15,902
|
13,224 |
| Profit as a percentage of turnover |
4.0%
|
4.9%
|
3.4% |
| Return on assets (ROA) |
13.8%
|
14.2%
|
10.2% |
| Current ratio |
222.2%
|
174.2%
|
160.5% |
| Return on equity (ROE) |
23.6%
|
33.3%
|
29.6% |
| Change turnover |
26,659
|
43,342
|
19,138 |
| Change turnover % |
5%
|
10%
|
4% |
| Chg. No. of employees |
5
|
-3
|
0 |
| Chg. No. of employees % |
16%
|
-9%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.